PM
Parametrica Management Portfolio holdings
AUM
$53.8M
This Quarter Return
+28.81%
1 Year Return
+45.44%
3 Year Return
+302.58%
5 Year Return
+406.02%
10 Year Return
–
AUM
$55.4M
AUM Growth
+$55.4M
(+14%)
Cap. Flow
+$1.53M
Cap. Flow
% of AUM
2.76%
Top 10 Holdings %
Top 10 Hldgs %
76.73%
Holding
54
New
8
Increased
11
Reduced
5
Closed
28
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$4.8M |
| 2 |
KE Holdings
BEKE
|
$3.84M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$3.4M |
| 4 |
Microsoft
MSFT
|
$3.11M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$2.57M |
Top Sells
| 1 |
Pfizer
PFE
|
$3.82M |
| 2 |
JD.com
JD
|
$3.46M |
| 3 |
Alibaba
BABA
|
$3.27M |
| 4 |
Wolfspeed
WOLF
|
$2.31M |
| 5 |
iShares Biotechnology ETF
IBB
|
$1.93M |
Sector Composition
| 1 | Communication Services | 34.96% |
| 2 | Technology | 28.81% |
| 3 | Healthcare | 20.59% |
| 4 | Consumer Discretionary | 8.71% |
| 5 | Real Estate | 6.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Microsoft
MSFT
$3.77T
| $7.88M | 14.23% |
27,346
+10,796
| +65% | +$3.11M |
|
|
2
Meta Platforms (Facebook)
META
$1.86T
| $7.84M | 14.15% |
37,000
+22,638
| +158% | +$4.8M |
|
|
3
Alphabet (Google) Class A
GOOGL
$2.57T
| $7.1M | 12.81% |
68,407
+32,807
| +92% | +$3.4M |
|
|
4
KE Holdings
BEKE
$20.8B
| $3.84M | 6.93% |
+203,892
| New | +$3.84M |
|
5
Baidu
BIDU
$32.8B
| $3.39M | 6.11% |
22,432
+7,232
| +48% | +$1.09M |
|
6
Pinduoduo
PDD
$171B
| $3.29M | 5.94% |
43,375
+25,400
| +141% | +$1.93M |
|
7
Eli Lilly
LLY
$657B
| $2.69M | 4.85% |
7,827
+627
| +9% | +$215K |
|
|
8
Regeneron Pharmaceuticals
REGN
$61.5B
| $2.57M | 4.63% |
+3,123
| New | +$2.57M |
|
9
Novo Nordisk
NVO
$251B
| $2.39M | 4.31% |
15,000
+1,100
| +8% | +$175K |
|
10
Mercado Libre
MELI
$125B
| $1.54M | 2.77% |
+1,165
| New | +$1.54M |
|
11
Adobe
ADBE
$151B
| $1.53M | 2.76% |
+3,968
| New | +$1.53M |
|
12
ServiceNow
NOW
$190B
| $1.46M | 2.63% |
3,140
+707
| +29% | +$329K |
|
13
NVIDIA
NVDA
$4.24T
| $1.41M | 2.54% |
5,063
-2,691
| -35% | -$747K |
|
14
Lantheus
LNTH
$3.73B
| $1.26M | 2.28% |
15,300
+1,100
| +8% | +$90.8K |
|
15
Applied Materials
AMAT
$128B
| $1.25M | 2.26% |
10,200
+1,432
| +16% | +$176K |
|
16
Advanced Micro Devices
AMD
$264B
| $1.2M | 2.16% |
12,200
-5,200
| -30% | -$510K |
|
17
Alnylam Pharmaceuticals
ALNY
$58.5B
| $1.19M | 2.15% |
5,953
-3,547
| -37% | -$711K |
|
18
Full Truck Alliance
YMM
$13.6B
| $1.08M | 1.94% |
141,513
-15,226
| -10% | -$116K |
|
19
Match Group
MTCH
$8.98B
| $1.05M | 1.89% |
+27,251
| New | +$1.05M |
|
20
10x Genomics
TXG
$1.74B
| $801K | 1.45% |
+14,361
| New | +$801K |
|
21
Iovance Biotherapeutics
IOVA
$807M
| $298K | 0.54% |
48,700
+800
| +2% | +$4.89K |
|
22
Arbe Robotics
ARBE
$141M
| $109K | 0.2% |
+34,287
| New | +$109K |
|
23
Fate Therapeutics
FATE
$120M
| $105K | 0.19% |
18,472
-13,782
| -43% | -$78.6K |
|
24
Century Therapeutics
IPSC
$42.5M
| $96.6K | 0.17% |
27,840
| – | – |
|
25
Sabre
SABR
$706M
| $51.5K | 0.09% |
+12,000
| New | +$51.5K |
|